Explore more publications!

The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on December 8, 2025

Phygital School Games engage thousands of students across Latin America
Amyotrophic Lateral Sclerosis Market Set to Grow at an Impressive CAGR of 4.01% Through 2035 | 1.295 (USD Billion)
Fantastic night of ROCK MEETS SOUL planned with John Oates plus Firefall plus Raydio and more at the Mizner Park Amp
Aesthetics Market Expected to Achieve a Strong 6.5% CAGR, to Reach USD 300 Billion by 2035
Bankaool partners with Maccorp to offer payments in 130 currencies
Fortuna Expands Southern Arc Mineralization with Drill Intercept of  1.7 g/t Au over 29.6 meters and a further 2.0 g/t Au over 20.0 meters from DSDD574 at the Diamba Sud Gold Project, Senegal
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
ASH 2025 : Cellectis présente son plan de développement pour renforcer les taux de réponse élevés obtenus avec éti-cel dans le LNH en rechute ou réfractaire
Bitget apporte des améliorations majeures à GetAgent avec des réponses plus intelligentes et un accès gratuit pour tous les utilisateurs
ビットゲット、ゲットエージェントの大幅アップグレードをリリース、よりスマートな応答と全ユーザー無料アクセスを実現
Bitget, GetAgent 대규모 업그레이드 발표… 더 똑똑한 응답 기능과 전 사용자 무료 이용 확대
Bitget Umum Naik Taraf Besar GetAgent, Menawarkan Respons Lebih Pintar dan Akses Percuma kepada Semua Pengguna
Bitget 发布 GetAgent 重大升级:响应更智能,所有用户免费使用
Bitget presenta importantes actualizaciones de GetAgent con respuestas más inteligentes y acceso gratuito para todos los usuarios
Bitget משחררת שדרוגים משמעותיים ל-GetAgent עם תגובות חכמות יותר וגישה בחינם לכל המשתמשים
Bitget Lança Importantes Atualizações para GetAgent com Respostas Mais Inteligentes e Acesso Gratuito para Todos os Usuários
Bitget 發佈 GetAgent 重大升級,提供更智能的回應並全面免費開放
Miltenyi Biomedicine stellt die Primäranalyse der zulassungsrelevanten DALY-2-EU-Studie zur Zweitlinientherapie des rezidivierten/refraktären großzelligen B-Zell-Lymphoms auf der 67. Jahrestagung der American Society of Hematology (ASH) vor

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions